| |
|
|
|
Intec Pharma Ord Shr  
|
|
0.2452 -0.006 (-0.02%) |
10-19 12:09 |
|
Open: |
0.257 |
Pre close: |
0.2509 |
Target:
|
0.33
|
|
High: |
0.26 |
Low: |
0.242 |
Resistance:
|
0.28
0.31
|
|
Volume: |
623,811 |
Market Cap: |
19M |
Support:
|
0.23
0.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.25
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.26 |
Signal(12,26,9): |
-0.01  |
|
MA(100): |
0.32 |
Stochastic Oscillator |
%K(14,3):
|
17.56 |
|
MA(250): |
0.36 |
%D(3): |
21.21 |
|
Average Volume(K) |
3-Month: |
455032
|
52-Week |
High:
|
0.79 |
|
10-Days: |
292874 |
Low: |
0.13 |
|
RSI |
RSI(14):
|
41.75 |
Change(%): |
-66.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.757 |
Return on Equity (ttm) |
-131.6 |
Shares Out. (M) |
78.96 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-35.2 |
Shares Float (M) |
60.13 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.19 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.02 |
|
Forward EPS |
-1.410 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
3240 |
|
Book Value (p.s.) |
0.230 |
EBITDA (p.s.) |
-0.232 |
P/E |
-0.32 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-18.14 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-13.47 |
P/CF |
-1.07 |
|
|
|
|
|
|
